Evidence map›Paper›PMID 36452305›Full record

ArticleFrontiers in cellular and infection microbiology2022

Phosphatidylinositol 4-kinase is a viable target for the radical cure of

Shengwei Ji, Eloiza May Galon, Moaz M Amer, Iqra Zafar, Masashi Yanagawa, Masahito Asada, Jinlin Zhou, Mingming Liu, Xuenan Xuan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Shengwei JiNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Eloiza May GalonNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Moaz M AmerNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Iqra ZafarNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Masashi YanagawaDepartment of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Masahito AsadaNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Jinlin ZhouShanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.
Mingming LiuSchool of Basic Medicine, Hubei University of Arts and Science, Xiangyang, China.
Xuenan XuanNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido, Japan.
Obihiro University of Agriculture and Veterinary Medicine · JPHubei University of Arts and Science · CNShanghai Veterinary Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human babesiosis is a global emerging tick-borne disease caused by infection with intra-erythrocytic parasites of the genus

Indexed as

BabesiaBabesia microtiBabesiosisGastropoda1-Phosphatidylinositol 4-KinaseAminopyridinesAnimalsAtovaquoneHumansImmunocompromised HostMiceMice, SCIDSulfones1-Phosphatidylinositol 4-KinaseAminopyridinesAtovaquoneMMV390048SulfonesBabesia microtibabesiosisMMV390048phosphatidylinositol 4-kinasetreatment

Identifiers

PMID36452305
PMCPMC9701728
OpenAlexW4309043426

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.